These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7909452)

  • 1. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients.
    Caligiuri MP; Lohr JB
    Biol Psychiatry; 1994 Jan; 35(2):104-11. PubMed ID: 7909452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isometric force control in schizophrenic patients with tardive dyskinesia.
    Vrtunski PB; Alphs LD; Meltzer HY
    Psychiatry Res; 1991 Apr; 37(1):57-72. PubMed ID: 1677772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients.
    Rapaport MH; Caligiuri MP; Lohr JB
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):817-27. PubMed ID: 9278953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia.
    Caligiuri MP; Harris MJ; Jeste DV
    Biol Psychiatry; 1988 Nov; 24(7):787-800. PubMed ID: 2906545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement disorder in never and minimally treated Nigerian schizophrenic patients.
    McCreadie RG; Ohaeri JU
    Br J Psychiatry; 1994 Feb; 164(2):184-9. PubMed ID: 7909712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal motor abnormalities associated with late-life psychosis.
    Caligiuri MP; Lohr JB; Panton D; Harris MJ
    Schizophr Bull; 1993; 19(4):747-54. PubMed ID: 7905662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuation of tardive dyskinesia.
    Caligiuri MP; Lohr JB; Vaughan RM; McAdams LA
    Biol Psychiatry; 1995 Sep; 38(5):336-9. PubMed ID: 7495929
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
    Rapaport MH; Lohr JB
    Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
    Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
    Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
    Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor mechanisms in schizophrenic patients with tardive dyskinesia.
    Vrtunski PB; Alphs LD; Meltzer HY
    Psychiatry Res; 1994 Oct; 54(1):71-86. PubMed ID: 7701030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involuntary disorders of movement in chronic schizophrenia--the role of the illness and its treatment.
    Owens DG
    Psychopharmacology Suppl; 1985; 2():79-87. PubMed ID: 2860663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF; Barnes TR; Speller J; Kibel D
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential mechanism underlying the voluntary suppression of tardive dyskinesia.
    Caligiuri MP; Lohr JB
    J Psychiatr Res; 1989; 23(3-4):257-66. PubMed ID: 2576826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.